Trident Lifeline has entered into a strategic alliance with National Institutes of Pharmaceutical Education and Research- Ahmedabad (NIPER-A) regarding the technology transfer of Vorinostat- one of the crucial medications for treating Cutaneous T-Cell Lymphoma (CTCL), a rare blood originated skin cancer which is currently unavailable in India. This collaboration aims to revolutionize the treatment landscape for CTCL patients by providing access to a high-quality, domestically produced Vorinostat.
The company will scale up the production of Vorinostat and introduce it to the Indian market by leveraging NIPER Ahmedabad's expertise. Furthermore, as a part of CSR initiative, the company aims to provide Vorinostat free of charge to economically disadvantaged patients.
Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: